Virtual Library

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P1.03 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Radiology/Staging/Screening
    • Presentations: 84
    • Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P1.03-025 - Serum KL-6 Levels in Patients with Lung Cancer

      14:30 - 14:30  |  Author(s): T. Yoshimasu

      • Abstract

      Loading...

  • +

    OA08 - Targeted Therapies in Brain Metastases

    • Type: Oral Session
    • Track: Advanced NSCLC
    • Presentations: 8
    • Moderators:D. Ball
    • Coordinates: 12/05/2016, 16:00 - 17:30, Schubert 1
  • +

    SC11 - ALK, ROS1 and Rare Mutations in NSCLC

    • Type: Science Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 5
    • Moderators:D. Kim
    • Coordinates: 12/05/2016, 16:00 - 17:30, Lehar 1-2
    • +

      SC11.02 - Resistance to ALK Inhibitor Therapy

      16:20 - 16:40  |  Author(s): S. Ou

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA07 - ALK-ROS1 in Advanced NSCLC

    • Type: Mini Oral Session
    • Track: Advanced NSCLC
    • Presentations: 12
    • Moderators:N. Singh
    • Coordinates: 12/06/2016, 11:00 - 12:30, Lehar 1-2
    • +

      MA07.02 - Updated Efficacy and Safety Data from the Phase 2 NP28761 Study of Alectinib in ALK-Positive Non-Small-Cell Lung Cancer

      11:06 - 11:12  |  Author(s): D..R. Camidge

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA08 - Treatment Monitoring in Advanced NSCLC

    • Type: Mini Oral Session
    • Track: Advanced NSCLC
    • Presentations: 12
    • Moderators:R. Perez-Soler
    • Coordinates: 12/06/2016, 11:00 - 12:30, Lehar 3-4
    • +

      MA08.01 - A Highly Sensitive Next-Generation Sequencing Platform for Detection of NSCLC EGFR T790M Mutation in Urine and Plasma

      11:00 - 11:06  |  Author(s): H. Wakelee

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA10 - EGFR Mutations

    • Type: Oral Session
    • Track: Biology/Pathology
    • Presentations: 8
    • Moderators:J. Spicer
    • Coordinates: 12/06/2016, 11:00 - 12:30, Strauss 1
    • +

      OA10.01 - Comprehensive Genomic Profiling and PDX Modeling of EGFR Exon 20 Insertions: Evidence for Osimertinib Based Dual EGFR Blockade

      11:00 - 11:10  |  Author(s): J.W. Riess

      • Abstract

      Loading...

  • +

    MA14 - Immunotherapy in Advanced NSCLC: Biomarkers and Costs

    • Type: Mini Oral Session
    • Track: Advanced NSCLC
    • Presentations: 12
    • Moderators:M. Reck
    • Coordinates: 12/06/2016, 16:00 - 17:30, Strauss 2
    • +

      MA14.01 - Updated Dataset Assessing Tumor Mutation Burden (TMB) as a Biomarker for Response to PD-1/PD-L1 Targeted Therapies in Lung Cancer (LC)

      16:00 - 16:06  |  Author(s): A.B. Schrock

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA16 - Novel Strategies in Targeted Therapy

    • Type: Mini Oral Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 12
    • Moderators:G. Purkalne
    • Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 2
    • +

      MA16.03 - Global RET Registry (GLORY): Activity of RET-Directed Targeted Therapies in RET-Rearranged Lung Cancers

      14:26 - 14:32  |  Author(s): O. Gautschi

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA16.09 - Antitumor Activity and Safety of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer

      15:14 - 15:20  |  Author(s): A. Drilon

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.02a - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 37
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.02a-016 - Pooled Efficacy and Safety Data from Two Phase II Studies (NP28673 and NP28761) of Alectinib in ALK+ Non-Small-Cell Lung Cancer (NSCLC)

      14:30 - 14:30  |  Author(s): J.C. Yang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.02c - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 103
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.02c-014 - Patients with Recurrence after Resection of Lung Cancer Are Good Candidates for the beyond over Progressive Disease Application of Bevacizumab

      14:30 - 14:30  |  Author(s): T. Yoshimasu

      • Abstract

      Loading...